These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22107038)

  • 1. Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
    Yelovitch S; Camden J; Weisman GA; Fischer B
    J Med Chem; 2012 Jan; 55(1):437-48. PubMed ID: 22107038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
    Nahum V; Tulapurkar M; Lévesque SA; Sévigny J; Reiser G; Fischer B
    J Med Chem; 2006 Mar; 49(6):1980-90. PubMed ID: 16539385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diadenosine 5',5''-(boranated)polyphosphonate analogues as selective nucleotide pyrophosphatase/phosphodiesterase inhibitors.
    Eliahu S; Lecka J; Reiser G; Haas M; Bigonnesse F; Lévesque SA; Pelletier J; Sévigny J; Fischer B
    J Med Chem; 2010 Dec; 53(24):8485-97. PubMed ID: 21090681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine 5'-O-(1-boranotriphosphate) derivatives as novel P2Y(1) receptor agonists.
    Nahum V; Zündorf G; Lévesque SA; Beaudoin AR; Reiser G; Fischer B
    J Med Chem; 2002 Nov; 45(24):5384-96. PubMed ID: 12431066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenine nucleotide analogues locked in a Northern methanocarba conformation: enhanced stability and potency as P2Y(1) receptor agonists.
    Ravi RG; Kim HS; Servos J; Zimmermann H; Lee K; Maddileti S; Boyer JL; Harden TK; Jacobson KA
    J Med Chem; 2002 May; 45(10):2090-100. PubMed ID: 11985476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrimidine ribonucleotides with enhanced selectivity as P2Y(6) receptor agonists: novel 4-alkyloxyimino, (S)-methanocarba, and 5'-triphosphate gamma-ester modifications.
    Maruoka H; Barrett MO; Ko H; Tosh DK; Melman A; Burianek LE; Balasubramanian R; Berk B; Costanzi S; Harden TK; Jacobson KA
    J Med Chem; 2010 Jun; 53(11):4488-501. PubMed ID: 20446735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel insulin secretagogue based on a dinucleoside polyphosphate scaffold.
    Eliahu S; Barr HM; Camden J; Weisman GA; Fischer B
    J Med Chem; 2010 Mar; 53(6):2472-81. PubMed ID: 20175517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.
    Azran S; Förster D; Danino O; Nadel Y; Reiser G; Fischer B
    J Med Chem; 2013 Jun; 56(12):4938-52. PubMed ID: 23751098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UDP made a highly promising stable, potent, and selective P2Y6-receptor agonist upon introduction of a boranophosphate moiety.
    Ginsburg-Shmuel T; Haas M; Grbic D; Arguin G; Nadel Y; Gendron FP; Reiser G; Fischer B
    Bioorg Med Chem; 2012 Sep; 20(18):5483-95. PubMed ID: 22901672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
    Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sp-2-propylthio-ATP-α-B and Sp-2-propylthio-ATP-α-B,β-γ-dichloromethylene are novel potent and specific agonists of the human P2Y₁₁ receptor.
    Haas M; Ben-Moshe I; Fischer B; Reiser G
    Biochem Pharmacol; 2013 Sep; 86(5):645-55. PubMed ID: 23810430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tools and drugs for uracil nucleotide-activated P2Y receptors.
    Rafehi M; Müller CE
    Pharmacol Ther; 2018 Oct; 190():24-80. PubMed ID: 29660366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.
    Tulapurkar ME; Laubinger W; Nahum V; Fischer B; Reiser G
    Br J Pharmacol; 2004 Jul; 142(5):869-78. PubMed ID: 15197109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotides Acting at P2Y Receptors: Connecting Structure and Function.
    Jacobson KA; Paoletta S; Katritch V; Wu B; Gao ZG; Zhao Q; Stevens RC; Kiselev E
    Mol Pharmacol; 2015 Aug; 88(2):220-30. PubMed ID: 25837834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist.
    Yelovitch S; Barr HM; Camden J; Weisman GA; Shai E; Varon D; Fischer B
    J Med Chem; 2012 Sep; 55(17):7623-35. PubMed ID: 22873688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
    Pendergast W; Yerxa BR; Douglass JG; Shaver SR; Dougherty RW; Redick CC; Sims IF; Rideout JL
    Bioorg Med Chem Lett; 2001 Jan; 11(2):157-60. PubMed ID: 11206448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine nucleotides with 4-alkyloxyimino and terminal tetraphosphate δ-ester modifications as selective agonists of the P2Y(4) receptor.
    Maruoka H; Jayasekara MP; Barrett MO; Franklin DA; de Castro S; Kim N; Costanzi S; Harden TK; Jacobson KA
    J Med Chem; 2011 Jun; 54(12):4018-33. PubMed ID: 21528910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
    Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic Strategies for Dinucleotides Synthesis.
    Appy L; Chardet C; Peyrottes S; Roy B
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31783537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural modifications of UMP, UDP, and UTP leading to subtype-selective agonists for P2Y2, P2Y4, and P2Y6 receptors.
    El-Tayeb A; Qi A; Nicholas RA; Müller CE
    J Med Chem; 2011 Apr; 54(8):2878-90. PubMed ID: 21417463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.